Volume | 109,318 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.2875 | Mínimo Máximo |
|||||
Minimo del Dia | 3.10 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.21 | 3.10 | 3.2875 | 3.20 | 3.18 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
1,119 | 109,318 | US$ 3.18 | US$ 347,639 | - | 2.67 - 9.2499 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:01 | 19 | US$ 3.20 | USD |
Información Financiera Reviva Pharmaceuticals Holdings Inc RVPH
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
198.19M | 22.65M | - | 0 | -39.26M | -1.73 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Reviva Pharmaceuticals Holdings Inc RVPH
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
16/2/2024 | 15:32 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
13/2/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
13/2/2024 | 16:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
02/2/2024 | 15:38 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
17/11/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
17/11/2023 | 15:03 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14/11/2023 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
30/10/2023 | 07:20 | Edgar (US Regulatory) | Form 8-K - Current report |
04/10/2023 | 16:03 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
04/10/2023 | 16:02 | Edgar (US Regulatory) | Form 8-K - Current report |
17/8/2023 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
14/8/2023 | 15:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Histórico de Datos RVPH
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.97 | 3.30 | 2.90 | 3.06 | 102,351 | 0.23 | 7.74% |
1 Month | 3.60 | 3.81 | 2.90 | 3.33 | 137,870 | -0.40 | -11.11% |
3 Months | 4.35 | 4.83 | 2.67 | 3.63 | 256,499 | -1.15 | -26.44% |
6 Months | 4.90 | 6.3001 | 2.67 | 4.22 | 404,795 | -1.70 | -34.69% |
1 Year | 7.24 | 9.2499 | 2.67 | 4.91 | 505,448 | -4.04 | -55.80% |
3 Years | 5.77 | 9.2499 | 0.53 | 3.58 | 431,228 | -2.57 | -44.54% |
5 Years | 9.46 | 9.61 | 0.53 | 4.69 | 494,184 | -6.26 | -66.17% |